BACKGROUND: Smaller hippocampal volumes relative to controls are among the most replicated neuroimaging findings in individuals with unipolar but not bipolar depression. Preserved hippocampal volumes in most studies of participants with bipolar disorder may reflect potential neuroprotective effects of lithium (Li). METHODS: To investigate hippocampal volumes in patients with bipolar disorder while controlling for Li exposure, we performed a meta-analysis of neuroimaging studies that subdivided patients based on the presence or absence of current Li treatment. To achieve the best coverage of literature, we categorized studies based on whether all or a majority, or whether no or a minority of patients were treated with Li. Hippocampal volumes were compared by combining standardized differences between means (Cohen d) from individual studies using random-effects models. RESULTS: Overall, we analyzed data from 101 patients with bipolar disorder in the Li group, 245 patients in the non-Li group and 456 control participants from 16 studies. Both the left and right hippocampal volumes were significantly larger in the Li group than in controls (Cohen d = 0.53, 95% confidence interval [CI] 0.18 to 0.88; Cohen d = 0.51, 95% CI 0.21 to 0.81, respectively) or the non-Li group (Cohen d = 0.93, 95% CI 0.56 to 1.31; Cohen d = 1.07, 95% CI 0.70 to 1.45, respectively), which had smaller left and right hippocampal volumes than the control group (Cohen d = -0.36, 95% CI -0.55 to -0.17; Cohen d = -0.38, 95% CI -0.63 to -0.13, respectively). There was no evidence of publication bias. LIMITATIONS: Missing information about the illness burden or lifetime exposure to Li and polypharmacy in some studies may have contributed to statistical heterogeneity in some analyses. CONCLUSION: When exposure to Li was minimized, patients with bipolar disorder showed smaller hippocampal volumes than controls or Li-treated patients. Our findings provide indirect support for the negative effects of bipolar disorder on hippocampal volumes and are consistent with the putative neuroprotective effects of Li. The preserved hippocampal volumes among patients with bipolar disorder in most individual studies and all previous meta-analyses may have been related to the inclusion of Li-treated participants.
BACKGROUND: Smaller hippocampal volumes relative to controls are among the most replicated neuroimaging findings in individuals with unipolar but not bipolar depression. Preserved hippocampal volumes in most studies of participants with bipolar disorder may reflect potential neuroprotective effects of lithium (Li). METHODS: To investigate hippocampal volumes in patients with bipolar disorder while controlling for Li exposure, we performed a meta-analysis of neuroimaging studies that subdivided patients based on the presence or absence of current Li treatment. To achieve the best coverage of literature, we categorized studies based on whether all or a majority, or whether no or a minority of patients were treated with Li. Hippocampal volumes were compared by combining standardized differences between means (Cohen d) from individual studies using random-effects models. RESULTS: Overall, we analyzed data from 101 patients with bipolar disorder in the Li group, 245 patients in the non-Li group and 456 control participants from 16 studies. Both the left and right hippocampal volumes were significantly larger in the Li group than in controls (Cohen d = 0.53, 95% confidence interval [CI] 0.18 to 0.88; Cohen d = 0.51, 95% CI 0.21 to 0.81, respectively) or the non-Li group (Cohen d = 0.93, 95% CI 0.56 to 1.31; Cohen d = 1.07, 95% CI 0.70 to 1.45, respectively), which had smaller left and right hippocampal volumes than the control group (Cohen d = -0.36, 95% CI -0.55 to -0.17; Cohen d = -0.38, 95% CI -0.63 to -0.13, respectively). There was no evidence of publication bias. LIMITATIONS: Missing information about the illness burden or lifetime exposure to Li and polypharmacy in some studies may have contributed to statistical heterogeneity in some analyses. CONCLUSION: When exposure to Li was minimized, patients with bipolar disorder showed smaller hippocampal volumes than controls or Li-treated patients. Our findings provide indirect support for the negative effects of bipolar disorder on hippocampal volumes and are consistent with the putative neuroprotective effects of Li. The preserved hippocampal volumes among patients with bipolar disorder in most individual studies and all previous meta-analyses may have been related to the inclusion of Li-treated participants.
Authors: John L Beyer; Maragatha Kuchibhatla; Martha E Payne; Melissa Moo-Young; Frederick Cassidy; James Macfall; K Ranga R Krishnan Journal: Am J Geriatr Psychiatry Date: 2004 Nov-Dec Impact factor: 4.105
Authors: Theo G M van Erp; Paul M Thompson; Tuula Kieseppä; Carrie E Bearden; Alexandria C Marino; Gil D Hoftman; Jari Haukka; Timo Partonen; Matti Huttunen; Jaakko Kaprio; Jouko Lönnqvist; Veli-Pekka Poutanen; Arthur W Toga; Tyrone D Cannon Journal: Hum Brain Mapp Date: 2011-03-31 Impact factor: 5.038
Authors: G J Moore; J M Bebchuk; K Hasanat; G Chen; N Seraji-Bozorgzad; I B Wilds; M W Faulk; S Koch; D A Glitz; L Jolkovsky; H K Manji Journal: Biol Psychiatry Date: 2000-07-01 Impact factor: 13.382
Authors: Alessandro Bertolino; Mark Frye; Joseph H Callicott; Venkata S Mattay; Rebecca Rakow; Jennifer Shelton-Repella; Robert Post; Daniel R Weinberger Journal: Biol Psychiatry Date: 2003-05-15 Impact factor: 13.382
Authors: Paolo Brambilla; Keith Harenski; Mark Nicoletti; Roberto B Sassi; Alan G Mallinger; Ellen Frank; David J Kupfer; Matcheri S Keshavan; Jair C Soares Journal: J Psychiatr Res Date: 2003 Jul-Aug Impact factor: 4.791
Authors: Nick C Patel; Melissa P DelBello; Kim M Cecil; Kevin E Stanford; Caleb M Adler; Stephen M Strakowski Journal: J Child Adolesc Psychopharmacol Date: 2008-04 Impact factor: 2.576
Authors: Barbara K Chen; Roberto Sassi; David Axelson; John P Hatch; Marsal Sanches; Mark Nicoletti; Paolo Brambilla; Matcheri S Keshavan; Neal D Ryan; Boris Birmaher; Jair C Soares Journal: Biol Psychiatry Date: 2004-09-15 Impact factor: 13.382
Authors: Robert M Post; Kirk D Denicoff; Gabriele S Leverich; Lori L Altshuler; Mark A Frye; Trisha M Suppes; A John Rush; Paul E Keck; Susan L McElroy; David A Luckenbaugh; Chad Pollio; Ralph Kupka; Willem A Nolen Journal: J Clin Psychiatry Date: 2003-06 Impact factor: 4.384
Authors: S Kittel-Schneider; T Wobrock; H Scherk; T Schneider-Axmann; S Trost; D Zilles; C Wolf; A Schmitt; B Malchow; A Hasan; M Backens; W Reith; P Falkai; O Gruber; A Reif Journal: Eur Arch Psychiatry Clin Neurosci Date: 2014-06-24 Impact factor: 5.270
Authors: C I Giakoumatos; P Nanda; I T Mathew; N Tandon; J Shah; J R Bishop; B A Clementz; G D Pearlson; J A Sweeney; C A Tamminga; M S Keshavan Journal: J Psychiatr Res Date: 2014-12-23 Impact factor: 4.791
Authors: Tomas Hajek; Jeffrey Cullis; Tomas Novak; Miloslav Kopecek; Ryan Blagdon; Lukas Propper; Pavla Stopkova; Anne Duffy; Cyril Hoschl; Rudolf Uher; Tomas Paus; L Trevor Young; Martin Alda Journal: Biol Psychiatry Date: 2012-07-20 Impact factor: 13.382
Authors: Martha Sajatovic; Sergio A Strejilevich; Ariel G Gildengers; Annemiek Dols; Rayan K Al Jurdi; Brent P Forester; Lars Vedel Kessing; John Beyer; Facundo Manes; Soham Rej; Adriane R Rosa; Sigfried Ntm Schouws; Shang-Ying Tsai; Robert C Young; Kenneth I Shulman Journal: Bipolar Disord Date: 2015-09-19 Impact factor: 6.744
Authors: Virginia E Sturm; Jennifer S Yokoyama; William W Seeley; Joel H Kramer; Bruce L Miller; Katherine P Rankin Journal: Proc Natl Acad Sci U S A Date: 2013-05-28 Impact factor: 11.205